Welcome to our dedicated page for InnovAge Holding SEC filings (Ticker: INNV), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
InnovAge Holding Corp. filings document the reporting framework for a Nasdaq-listed healthcare services company built around the Program of All-inclusive Care for the Elderly (PACE). Form 8-K reports furnish quarterly operating results, financial-condition updates, Regulation FD investor presentations, guidance-related materials, and governance events such as director appointments and executive transitions.
Proxy materials describe annual meeting matters, classified-board elections, committee governance, executive and director compensation, stockholder voting procedures, and auditor ratification. The filings also identify InnovAge common stock on the Nasdaq Global Select Market and include emerging-growth-company status, common-stock registration details, capital-structure information, and public-company reporting obligations tied to its PACE care model.
Nicole D'Amato, Chief Legal Officer of InnovAge Holding Corp. (INNV), reported a transaction dated 08/15/2025 on a Form 4. The filing discloses 14,303 shares of Common Stock were disposed of at $3.43 per share pursuant to tax withholding related to the vesting and settlement of restricted stock units. After the withholding disposition, the reporting person beneficially owned 319,807 shares. The Form 4 was signed on 08/18/2025. The filing explicitly states the shares were withheld to satisfy tax obligations and does not indicate an open-market sale or change in control.